Skip to main content
. 2022 Aug 18;15(8):1370–1380. doi: 10.18240/ijo.2022.08.22

Table 1. Characteristics of included studies.

Study Year Region Design No. eye
Mean±SD age (y)
Gender (F/M)
Device (SD-OCT) Scan area of ONH (mm2) MD of the VF (dB)
Severity of glaucoma Onset time of NAION
NAION POAG NAION POAG NAION POAG NAION POAG
Shin 2021[17] Korea CS, R 27 27 65.2±7.8 61.7±11.1 11/16 17/10 Cirrus 3.45 mm circle -15.13±8.34 -15.11±7.57 Not indicated >6mo
Hondur 2021[18] Turkey CS 21 26 61±7 62±11 9/12 13/13 Spectralis 4.5×4.5 -18.79±6.13 -20.99±6.36 Severe >6mo
Fard 2020[19] Iran CS, P 19 37 57.4±12.2 63.6±0.4 N/A N/A Optovue 3.4 mm circle -14.0±5.3 -12.7±5.5 Moderate to severe >6mo
Robolleda 2019[20] Spain CS 23 25 68.6±10.3 72.3±9.8 12/11 11/14 Spectralis 3.5 mm circle -14.7±8.6 -12.9±8.32 Not indicated >6mo
Resch 2018[22] Austria CS 20 20 66.8±8.3 71.2±6.0 8/12 11/9 Spectralis & Cirrus 3.4 mm circle -9.85±4.79 -10.24±4.71 Moderate to severe >6mo
Fard 2018[24] Iran CS 31 42 54.1±11 60.2±8 15/16 16/26 Spectralis 3.45 mm circle -18.4±8.6 -17.2±8.6 Moderate to severe >6mo
Liu 2017[25] Taiwan, China CS, R 10 16 59.9±10.7 53.75±10.21 6/4 7/9 Optovue 3.45 mm circle -12.78±6.34 -9.69±3.56 Moderate >3mo
Lee 2017[26] Korea CS, R 35 70 63.6±8.6 64.4±9.0 20/15 40/30 Cirrus Optic disc cube 200×200 -17.7±8.7 -13.5±7.5 Moderate to severe >3mo
Fard 2016[29] Iran CS 30 32 58.4±10.5 65.6±13.1 17/13 10/22 Spectralis 3.4 mm circle -16.47±9.05 -16.28±9.98 Moderate to severe >3mo
Fard 2016[28] Iran CS 42 32 58.02±8.83 64.59±9.79 22/20 10/22 Spectralis 3.4 mm circle -16.47±9.05 -16.28±9.98 Moderate to severe >3mo

F/M: Female/male; SD-OCT: Spectral-domain optical coherence tomography; ONH: Optic nerve head; MD: Mean deviation; VF: Visual field; NAION: Non-arteritic anterior ischemic optic neuropathy; POAG: Primary open angle glaucoma; CS: Cross-sectional study; P: Prospective study; R: Retrospective study.